Search Results - "Noviello, D"
-
1
Trust in telemedicine from IBD outpatients during the COVID-19 pandemic
Published in Digestive and liver disease (01-03-2021)Get full text
Journal Article -
2
AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn's disease is suppressed by rfaP and ybaT deletion
Published in Gut microbes (31-12-2024)“…Mucosal enrichment of the Adherent-Invasive (AIEC) pathotype and the expansion of pathogenic IFNγ-producing Th17 (pTh17) cells have been linked to Crohn's…”
Get full text
Journal Article -
3
-
4
P1237 Development of an algorithm to identify the best donor-recipient match for FMT in IBD patients based on immune system/microbiota interactions
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background IBD are characterized by uncontrolled immune responses, in genetically predisposed individuals, to the dysbiotic microbiota. Its modulation…”
Get full text
Journal Article -
5
-
6
OC.07.2 FUNCTIONAL GASTROINTESTINAL AND SOMATOFORM SYMPTOMS FIVE MONTHS AFTER SARS-COV-2 INFECTION: A CONTROLLED COHORT STUDY
Published in Digestive and liver disease (01-09-2021)Get full text
Journal Article -
7
P528 Feasibility, satisfaction and machine learning analysis of factors influencing IBD patients’ trust in the mobile application Care4today IBD
Published in Journal of Crohn's and colitis (21-01-2022)“…Abstract Background The use of telemedicine for the management of patients with Inflammatory Bowel Disease (IBD) has developed quickly over the past few years…”
Get full text
Journal Article -
8
P237 Superior predictive value of intestinal ultrasound over endoscopic severity for colectomy risk in patients with ulcerative colitis
Published in Journal of Crohn's and colitis (30-01-2023)“…Abstract Background Up to 15% of patients with ulcerative colitis (UC) do not respond to medical therapies and ultimately require colectomy for disease…”
Get full text
Journal Article -
9
-
10
P981 Risankizumab, but not ustekinumab or vedolizumab, downregulates IL-23-induced mucosal pathogenic Th17 cells in patients with Crohn’s disease
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background We recently described an interleukin(IL)-23-inducible pathogenic subset of CCR6+CXCR3-CCR5+ mucosal T helper (Th)17 cells (pTh17)…”
Get full text
Journal Article -
11
P1105 Short-term exposure to environmental air pollution and inflammatory bowel disease flares: a time-stratified case cross-over study
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Some epidemiological studies suggest that long-term exposure to environmental air pollutants, such as particulate matter (PM), could have a…”
Get full text
Journal Article -
12
P504 Prevalence of gastrointestinal infections in ulcerative colitis patients assessed with QIASTAT-DX® GASTROINTESTINAL PANEL 2
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background In inflammatory bowel disease (IBD), an acute clinical flare may be due to either disease exacerbation or an enteric infection. Thus, it is…”
Get full text
Journal Article -
13
OC.14.6 ATTITUDES TOWARDS VACCINATIONS IN AN ITALIAN COHORT OF IBD PATIENTS
Published in Digestive and liver disease (01-03-2023)Get full text
Journal Article -
14
P921 Maintenance of clinical, biochemical and transmural remission in inflammatory bowel disease patients switching from intravenous to subcutaneous infliximab
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Subcutaneous (SC) infliximab (IFX) effectively maintains biochemical, clinical and endoscopic remission in inflammatory bowel disease (IBD)…”
Get full text
Journal Article -
15
-
16
P908 Real-life effectiveness and safety of tofacitinib and vedolizumab as a second-line therapy in anti-TNFs experienced patients ulcerative colitis: preliminary results of an IGIBD study (VE2TO-UC)
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Drug positioning in ulcerative colitis (UC) patients refractory to anti-tumor necrosis factor (TNF) is still debated. We aimed to compare…”
Get full text
Journal Article -
17
P508 Pre-operative exposure to tofacitinib is as safe as biologics in patients with ulcerative colitis undergoing colectomy: a multicentre observational study
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background Patients with ulcerative colitis (UC) receiving immunomodulators are at substantial risk of colectomy. Since robust evidence regarding the…”
Get full text
Journal Article -
18
P674 Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy : results from a real-life multicenter cohort
Published in Journal of Crohn's and colitis (30-01-2023)“…Abstract Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory disease affecting skin that bears apocrine glands and is characterised…”
Get full text
Journal Article -
19
OP32 The gut virome-colonizing Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo
Published in Journal of Crohn's and colitis (30-01-2023)“…Abstract Background Ulcerative colitis (UC) is a chronic inflammatory disorder with an unknown etiology1. Over recent years, a growing body of evidence has…”
Get full text
Journal Article -
20
P463 COVID-19 vaccination willingness and hesitancy in patients with Inflammatory Bowel Diseases (IBD): analysis of determinants in a national survey of the Italian IBD patients’ association (AMICI Onlus)
Published in Journal of Crohn's and colitis (27-05-2021)“…Abstract Background Vaccine hesitancy, the delay in acceptance or refusal of vaccination despite its availability, represents a threat to the diffusion and…”
Get full text
Journal Article